Deeply saddened : Serum CEO after loss of lives due to fire at Pune plant
Adar Poonawalla, Chief Executive Officer (CEO) of the Serum Institute of India poses for a picture at the Serum Institute of India, Pune.
(REUTERS) We are deeply saddened and offer our deepest condolences to the family members of the departed, said Adar Poonawalla
The affected building where the fire broke out was an under-construction unit near the main gate of the 100-acre campus
Share Via
Read Full Story
CEO of Serum Institute of India, Adar Poonawalla, expressed condolences after five people died due to a fire breaking out at the company s Pune plant today afternoon.
Fire breaks out at Serum Institute of India s plant in Pune, Covishield production not hit
The blaze was reported at an under-construction building in the Manjri area of the city. The Serum Institute of India s plant is spread over 100 acres in Pune
BusinessToday.In | January 21, 2021 | Updated 16:23 IST
Vaccine production was not being carried out at the Serum Institute of India s under-construction building where the fire broke out
A massive fire broke out at Terminal 1 gate of Serum Institute of India in Pune on Thursday afternoon.
The blaze was reported at an under-construction building in the Manjri area of the city. The SII plant is spread over 100 acres in Pune.
The pandemic has kick-started a digital infodemic that has been as problematic as the virus itself. Misinformation about the vaccines now could spark another health crisis
Health minister Sudhakar defends Covaxin, says it s safe daijiworld.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from daijiworld.com Daily Mail and Mail on Sunday newspapers.
Three days on, Telangana yet to roll out local vax Covaxin
By
Mohammed Shafeeq ( IANS) |
Published on
Wed, Jan 20 2021 22:03 IST |
0 Views
Covaxin generated excellent safety data, says Bharat Biotech. Image Source: IANS News
Hyderabad, Jan 20 : Telangana has still not rolled out Covaxin, developed by Hyderabad-based Bharat Biotech, apparently due to fact that the Centre has allowed its use in clinical trial mode as its phase 3 trials were still continuing. During the three days of vaccination so far, the state authorities administered only Covishield. Nearly 70,000 public health workers in the state have taken the jab.
While state health officials maintain they will start giving Covaxin once they receive sufficient number of doses, it is the current format prescribed by the Indian Council of Medical Research (ICMR) which is delaying the rollout of the local product.